Prevention strategies for blood-borne viruses-in the Era of vaccines, direct acting antivirals and antiretroviral therapy.

2.50
Hdl Handle:
http://hdl.handle.net/10033/620859
Title:
Prevention strategies for blood-borne viruses-in the Era of vaccines, direct acting antivirals and antiretroviral therapy.
Authors:
Pfaender, Stephanie; von Hahn, Thomas; Steinmann, Joerg; Ciesek, Sandra; Steinmann, Eike ( 0000-0002-8771-4262 )
Abstract:
Blood-borne viruses, such as hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and the facultative blood-borne hepatitis E virus, are considered a major public health problem given that they are accountable for millions of deaths each year. Treatment options, including effective vaccine design, development of antiviral strategies and the implementation of antiretroviral therapy have improved substantially over the last couple of years and contribute to successful treatment and prevention of these infectious diseases. In this review, we summarise the current knowledge and concepts in prevention of transmission of these blood-borne viruses.
Affiliation:
Twincore Centre of Experimental and Clinical Infection Research; a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover 30625, Germany.
Citation:
Prevention strategies for blood-borne viruses-in the Era of vaccines, direct acting antivirals and antiretroviral therapy. 2016, 26 (5):330-9 Rev. Med. Virol.
Journal:
Reviews in medical virology
Issue Date:
Sep-2016
URI:
http://hdl.handle.net/10033/620859
DOI:
10.1002/rmv.1890
PubMed ID:
27185010
Type:
Article
Language:
en
ISSN:
1099-1654
Appears in Collections:
publications of the research group virus transmission ([TC]VIRT)

Full metadata record

DC FieldValue Language
dc.contributor.authorPfaender, Stephanieen
dc.contributor.authorvon Hahn, Thomasen
dc.contributor.authorSteinmann, Joergen
dc.contributor.authorCiesek, Sandraen
dc.contributor.authorSteinmann, Eikeen
dc.date.accessioned2017-03-15T09:04:49Z-
dc.date.available2017-03-15T09:04:49Z-
dc.date.issued2016-09-
dc.identifier.citationPrevention strategies for blood-borne viruses-in the Era of vaccines, direct acting antivirals and antiretroviral therapy. 2016, 26 (5):330-9 Rev. Med. Virol.en
dc.identifier.issn1099-1654-
dc.identifier.pmid27185010-
dc.identifier.doi10.1002/rmv.1890-
dc.identifier.urihttp://hdl.handle.net/10033/620859-
dc.description.abstractBlood-borne viruses, such as hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and the facultative blood-borne hepatitis E virus, are considered a major public health problem given that they are accountable for millions of deaths each year. Treatment options, including effective vaccine design, development of antiviral strategies and the implementation of antiretroviral therapy have improved substantially over the last couple of years and contribute to successful treatment and prevention of these infectious diseases. In this review, we summarise the current knowledge and concepts in prevention of transmission of these blood-borne viruses.en
dc.language.isoenen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titlePrevention strategies for blood-borne viruses-in the Era of vaccines, direct acting antivirals and antiretroviral therapy.en
dc.typeArticleen
dc.contributor.departmentTwincore Centre of Experimental and Clinical Infection Research; a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover 30625, Germany.en
dc.identifier.journalReviews in medical virologyen

Related articles on PubMed

This item is licensed under a Creative Commons License
Creative Commons
All Items in HZI are protected by copyright, with all rights reserved, unless otherwise indicated.